Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMKO0BQ)

Drug Name

BLD-2660 Drug Info

Synonyms

BLD 2660

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]

Therapeutic Class

Antiviral Agents

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
HUMAN calpain-1/calpain small subunit 1 heterodimer (CAPN1/CAPNS1)	TT45V0U	CAN1_HUMAN/CPNS1_HUMAN	Inhibitor	[1]
HUMAN calpain-2/calpain small subunit 1 heterodimer (CAPN2/CAPNS1)	TTO361H	CAN2_HUMAN/CPNS1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04334460) Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects. U.S. National Institutes of Health.